Workflow
Kernal Bio Joins Lilly Gateway Labs to Accelerate In Vivo Cell Therapies
礼来礼来(US:LLY) Businesswire·2025-10-03 13:00

BOSTON--(BUSINESS WIRE)-- #AI--Kernal Bio retains strategic independence, while gaining access to shared resources, operational support and Lilly's global network of experts. ...